Tower Research Capital (TRC)’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28K | Sell |
395
-39
| -9% | -$225 | ﹤0.01% | 4673 |
|
|
2025
Q1 | $3.48K | Buy |
434
+234
| +117% | +$1.87K | ﹤0.01% | 4403 |
|
|
2024
Q4 | $2.14K | Buy |
200
+191
| +2,122% | +$2.05K | ﹤0.01% | 4897 |
|
|
2024
Q3 | $119 | Hold |
9
| – | – | ﹤0.01% | 5487 |
|
|
2024
Q2 | $138 | Sell |
9
-268
| -97% | -$4.11K | ﹤0.01% | 5453 |
|
|
2024
Q1 | $7.76K | Sell |
277
-135
| -33% | -$3.78K | ﹤0.01% | 4145 |
|
|
2023
Q4 | $9.22K | Buy |
+412
| New | +$9.22K | ﹤0.01% | 4421 |
|
|
2023
Q3 | – | Sell |
-33
| Closed | -$835 | – | 5955 |
|
|
2023
Q2 | $835 | Sell |
33
-166
| -83% | -$4.2K | ﹤0.01% | 5508 |
|
|
2023
Q1 | $5K | Buy |
199
+88
| +79% | +$2.21K | ﹤0.01% | 4933 |
|
|
2022
Q4 | $3K | Sell |
111
-816
| -88% | -$22.1K | ﹤0.01% | 5153 |
|
|
2022
Q3 | $28K | Buy |
927
+525
| +131% | +$15.9K | ﹤0.01% | 3648 |
|
|
2022
Q2 | $16K | Buy |
402
+98
| +32% | +$3.9K | ﹤0.01% | 4000 |
|
|
2022
Q1 | $17K | Buy |
304
+89
| +41% | +$4.98K | ﹤0.01% | 3675 |
|
|
2021
Q4 | $21K | Buy |
215
+181
| +532% | +$17.7K | ﹤0.01% | 3590 |
|
|
2021
Q3 | $9K | Sell |
34
-47
| -58% | -$12.4K | ﹤0.01% | 4410 |
|
|
2021
Q2 | $25K | Buy |
81
+28
| +53% | +$8.64K | ﹤0.01% | 3669 |
|
|
2021
Q1 | $35K | Buy |
+53
| New | +$35K | ﹤0.01% | 3414 |
|